Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Alexander

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal AdenocarcinomasSimona Corso, Filippo Pietrantonio, Maria Apicella, et al.
Neuro-Oncology|March 11, 2015
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastomaShakti H Ramkissoon, Wenya Linda Bi, Steven E Schumacher, et al.
Science Translational Medicine|February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVeronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult GlioblastomaAnne-Florence Blandin, Ross Giglio, Maya Srikanth Graham, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II TrialPatrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal AdenocarcinomasSimona Corso, Filippo Pietrantonio, Maria Apicella, et al.
Neuro-Oncology|March 11, 2015
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastomaShakti H Ramkissoon, Wenya Linda Bi, Steven E Schumacher, et al.
Science Translational Medicine|February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVeronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult GlioblastomaAnne-Florence Blandin, Ross Giglio, Maya Srikanth Graham, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II TrialPatrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 16